Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-Canal Ketorolac for Post-Endodontic Pain
NCT07064083Phase 1Completed
- Sponsor
- Al-Azhar University
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketorolac (3 arms), sponsored by Al-Azhar University. Primary endpoint: Post-endodontic pain at 7 days. Started Aug 2025; status: completed.
02
Drugs
ketorolac
Beyond the preview
Go deeper on NCT07064083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07064083.